Skip to main content

Sagar D. Sardesai, MBBS, on the Approval of ORSERDU™

Videos — August 1, 2023
Sagar D. Sardesai, MBBS
Medical Oncologist
The Ohio State University
Columbus, OH

Dr. Sardesai, medical oncologist at The Ohio State University in Columbus, OH, discusses key considerations relating to the approval of ORSERDU (elacestrant), including appropriate patient selection, the clinical relevance of ESR1 mutations, and key takeaways from the EMERALD trial.

Related Items